Natixis Advisors
RDY icon

Natixis Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Natixis Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,890
Closed -$292K – 1713
2025
Q3 		$292K Sell
20,890
-518
-2% -$7.45K ﹤0.01% 1589
2025
Q2 		$322K Sell
21,408
-5,284
-20% -$75.5K ﹤0.01% 1540
2025
Q1 		$352K Sell
26,692
-30,474
-53% -$420K ﹤0.01% 1522
2024
Q4 		$903K Buy
57,166
+2,481
+5% +$37.3K ﹤0.01% 1333
2024
Q3 		$174K Buy
54,685
+3,675
+7% +$59.1K ﹤0.01% 1566
2024
Q2 		$777K Buy
+51,010
New +$731K ﹤0.01% 1325
2024
Q1 		– Sell
-57,875
Closed -$805K – 1571
2023
Q4 		$805K Sell
57,875
-39,935
-41% -$534K ﹤0.01% 1270
2023
Q3 		$1.31M Buy
+97,810
New +$1.32M ﹤0.01% 1107
2023
Q2 		– Sell
-130,065
Closed -$1.48M – 1510
2023
Q1 		$1.48M Buy
+130,065
New +$1.4M 0.01% 1031
2017
Q2 		– Sell
-91,635
Closed -$736K – 1053
2017
Q1 		$736K Sell
91,635
-4,645
-5% -$40.1K 0.01% 918
2016
Q4 		$872K Sell
96,280
-960
-1% -$8.93K 0.01% 861
2016
Q3 		$903K Sell
97,240
-24,030
-20% -$229K 0.01% 823
2016
Q2 		$1.24M Sell
121,270
-3,615
-3% -$33.1K 0.02% 751
2016
Q1 		$1.13M Sell
124,885
-28,315
-18% -$253K 0.02% 769
2015
Q4 		$1.42M Sell
153,200
-7,150
-4% -$78.3K 0.02% 685
2015
Q3 		$2.05M Sell
160,350
-20,190
-11% -$251K 0.04% 594
2015
Q2 		$2M Buy
180,540
+16,405
+10% +$181K 0.03% 634
2015
Q1 		$1.87M Buy
164,135
+19,410
+13% +$206K 0.03% 639
2014
Q4 		$1.46M Buy
144,725
+1,995
+1% +$21K 0.03% 697
2014
Q3 		$1.5M Sell
142,730
-349,965
-71% -$3.29M 0.03% 676
2014
Q2 		$4.25M Buy
+492,695
New +$4.14M 0.06% 483

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Natixis Advisors's RDY Position: Q4 2025 in Review

Natixis Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 20,890 shares — an estimated $292K sold.

Natixis Advisors first reported a position in RDY in Q2 2014 and held it in 21 quarters. The position peaked at $4.25M in Q2 2014. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Natixis Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Natixis Advisors sold 20,890 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $292K.
  • Natixis Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 21 quarters.
  • Natixis Advisors's Dr. Reddy's Laboratories position peaked at $4.25M in Q2 2014.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Natixis Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.